![ETF Series Solutions Trust Range Cancer Therapeutics](/common/images/company/N_CNCR.png)
ETF Series Solutions Trust Range Cancer Therapeutics (CNCR)
NASDAQ
The current CNCR market cap is 12.78M. The company's latest EPS is USD -5.7713 and P/E is -2.77.
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 224k | 177k | 190k | 153k | 70k |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | -13.61M | 10.92M | 5.7M | -17.58M | -4.62M |
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 35.2M | 40.32M | 44.47M | 23.25M | 9.65M |
Total Liabilities | 1.01M | 26k | 29k | 17k | 6k |
Total Equity | 34.2M | 40.29M | 44.44M | 23.23M | 9.64M |
Market Cap | 12.78M |
Price to Earnings Ratio | -2.77 |
Price to Sales Ratio | 182.74 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 1.33 |
Dividend Yield | - |
Shares Outstanding | 800k |
Average Volume (1 week) | 6.85k |
Average Volume (1 Month) | 15.43k |
52 Week Change | 25.16% |
52 Week High | 18.00 |
52 Week Low | 9.22 |
Spread (Intraday) | 7.94 (39.94%) |
Company Name | ETF Series Solutions Trust Range Cancer Therapeutics |
Address |
615 east michigan st milwaukee, wisconsin 53202 |
Website | https://www.loncarfunds.com |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.